Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions

During pasteurization and storage of albumin products, Sodium octanoate (Oct) and N-acethyl-l-tryptophan (N-AcTrp) are used as the thermal stabilizer and the antioxidant for human serum albumin (HSA), respectively. We recently reported that N-acethyl-l-methionine (N-AcMet) is an antioxidant for HSA,...

Full description

Bibliographic Details
Main Authors: Kawai, A., Chuang, Victor, Kouno, Y., Yamasaki, K., Miyamoto, S., Anraku, M., Otagiri, M.
Format: Journal Article
Published: Elsevier BV 2017
Online Access:http://hdl.handle.net/20.500.11937/53781
_version_ 1848759226781925376
author Kawai, A.
Chuang, Victor
Kouno, Y.
Yamasaki, K.
Miyamoto, S.
Anraku, M.
Otagiri, M.
author_facet Kawai, A.
Chuang, Victor
Kouno, Y.
Yamasaki, K.
Miyamoto, S.
Anraku, M.
Otagiri, M.
author_sort Kawai, A.
building Curtin Institutional Repository
collection Online Access
description During pasteurization and storage of albumin products, Sodium octanoate (Oct) and N-acethyl-l-tryptophan (N-AcTrp) are used as the thermal stabilizer and the antioxidant for human serum albumin (HSA), respectively. We recently reported that N-acethyl-l-methionine (N-AcMet) is an antioxidant for HSA, which is superior to N-AcTrp when it is especially exposed to light during storage. The objective of the present study is to clarify the molecular mechanism responsible for the HSA protective effect of Oct and N-AcMet based on their ternary complex structure. Crystal structure of the HSA-Oct-N-AcMet complex showed that one N-AcMet molecule is bound to the entrance of drug site 1 of HSA, and its side chain, which is susceptible to the oxidation, is exposed to the solvent. At the same time, two Oct binding sites are observed in drug sites 1 and 2 of HSA, respectively, and each Oct molecule occupies the hydrophobic cavity in them. These results indicate the molecular mechanism responsible for the HSA stabilization by these small molecules as follows. N-AcMet seals the entrance of drug site 1 while it acts as an antioxidant for HSA. Oct is chiefly bound to drug site 2 of HSA and it increases the thermal stability of HSA because of the occupying the largest intra-cavity of sub-domain IIIA in HSA. These findings suggest that N-AcMet acts positively as useful stabilizer for albumin formulated products such as functionalized HSA and HSA fusion proteins.
first_indexed 2025-11-14T09:56:31Z
format Journal Article
id curtin-20.500.11937-53781
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:56:31Z
publishDate 2017
publisher Elsevier BV
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-537812017-10-23T03:27:11Z Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions Kawai, A. Chuang, Victor Kouno, Y. Yamasaki, K. Miyamoto, S. Anraku, M. Otagiri, M. During pasteurization and storage of albumin products, Sodium octanoate (Oct) and N-acethyl-l-tryptophan (N-AcTrp) are used as the thermal stabilizer and the antioxidant for human serum albumin (HSA), respectively. We recently reported that N-acethyl-l-methionine (N-AcMet) is an antioxidant for HSA, which is superior to N-AcTrp when it is especially exposed to light during storage. The objective of the present study is to clarify the molecular mechanism responsible for the HSA protective effect of Oct and N-AcMet based on their ternary complex structure. Crystal structure of the HSA-Oct-N-AcMet complex showed that one N-AcMet molecule is bound to the entrance of drug site 1 of HSA, and its side chain, which is susceptible to the oxidation, is exposed to the solvent. At the same time, two Oct binding sites are observed in drug sites 1 and 2 of HSA, respectively, and each Oct molecule occupies the hydrophobic cavity in them. These results indicate the molecular mechanism responsible for the HSA stabilization by these small molecules as follows. N-AcMet seals the entrance of drug site 1 while it acts as an antioxidant for HSA. Oct is chiefly bound to drug site 2 of HSA and it increases the thermal stability of HSA because of the occupying the largest intra-cavity of sub-domain IIIA in HSA. These findings suggest that N-AcMet acts positively as useful stabilizer for albumin formulated products such as functionalized HSA and HSA fusion proteins. 2017 Journal Article http://hdl.handle.net/20.500.11937/53781 10.1016/j.bbapap.2017.04.004 Elsevier BV restricted
spellingShingle Kawai, A.
Chuang, Victor
Kouno, Y.
Yamasaki, K.
Miyamoto, S.
Anraku, M.
Otagiri, M.
Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions
title Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions
title_full Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions
title_fullStr Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions
title_full_unstemmed Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions
title_short Crystallographic analysis of the ternary complex of octanoate and N-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions
title_sort crystallographic analysis of the ternary complex of octanoate and n-acetyl-l-methionine with human serum albumin reveals the mode of their stabilizing interactions
url http://hdl.handle.net/20.500.11937/53781